Forsiden ENOVA

Group photo from 2nd enova workshop

ENOVA is a science and technology “Network on Vaccine Adjuvants”, funded by COST through the EU Framework Programme Horizon 2020. ENOVA is coordinated by the Vaccine Formulation Institute (UK) and brings together European experts and stakeholders working in different areas of adjuvant and vaccine R&D, including both prophylactic and therapeutic applications as well as human and veterinary vaccines.  ENOVA’s members include industry, academic, and government institutions. The ultimate goals of the network are to facilitate communication and the exchange of information among its membership, to ensure that new discoveries are widely disseminated so that their potential can be of optimal benefit, to promote the best use of existing adjuvant technologies, and to encourage and support the development of novel adjuvants.

Log in (restricted)

News

  • TRANSVAC: European Training in Vaccinology May 8, 2019 4:22 PM

    The fourth call is open from 1 April 2019 – 1 st June 2019. It covers 3 modules:

    • M6 - CyTOF conducted at CEA, Fontenay-aux-Roses, France (19-20 September 2019)
    • M7 - Flow Cytometry organized also by CEA, Fontenay-aux-Roses, France (18-19 September 2019)
    • M9 - Key considerations and best practices for viral vaccine process development, scale-up and implementation at manufacturing scale including single use technologies, organized by VFI together with Merck at Merck/M Lab permises in Molsheim, France (10-11 September 2019)
  • rome Apply for post doc fellowship! Apr. 11, 2019 11:24 AM

    iCARE-2 is an international fellowship program co-funded by AIRC and the European Union, intended to promote the mobility of experienced researchers to and from Italy. Deadline for submission in June 2019.

  • 5th Call for TRANSVAC Vaccine Development Services Mar. 6, 2019 7:48 AM

    TRANSVAC2 project offers high-quality technical services to support the development of prophylactic and therapeutic vaccines for both human and animal use. These services are not restricted to any disease in particular.

  • NEW DEADLINE: ENOVA Training School on “Immunoactive carbohydrates and adjuvants Feb. 27, 2019 1:56 PM

    We have a limited number of places left on the next ENOVA Training School on “Immunoactive carbohydrates and adjuvants: antibacterial vaccines from research to clinical trials” in Sienna which is running from the 2 nd to 4 th April. The deadline for applications has been extended to March 8th.

    The Training School is suitable for Ph.D. students and researchers who have a basic knowledge of analytical and organic chemistry and would like to increase their knowledge of vaccine development specifically in the area carbohydrate-based vaccines.

    https://www.enova-adjuvant.eu/training/

Events